Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCCG-ALL-2020 pediatric acute lymphoblastic leukemia protocol
ChiCTR2000035264Phase 3Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methotrexate, dexamethasone, prednisone and dasatinib in acute lymphoblastic leukemia (ALL) (5 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Event-free survival and Overall survival. Started Aug 2020; status: recruiting.
02
Drugs
methotrexatedexamethasoneprednisonedasatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ChiCTR2000035264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035264.